Associated Papers
Reduced net charge and heterogeneity of pI isoforms in familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase.
Roudeau S et al.
Electrophoresis, 2015
SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration.
Milani P et al.
Oxidative Medicine and Cellular Longevity, 2013
Biology of mitochondria in neurodegenerative diseases.
Martin LJ
Progress in Molecular Biology and Translational Science, 2012
Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cord.
Zhai J et al.
The Febs Journal, 2009
Sod2 haploinsufficiency does not accelerate aging of telomere dysfunctional mice.
Guachalla LM et al.
Aging, 2009
Different regulation of wild-type and mutant Cu,Zn superoxide dismutase localization in mammalian mitochondria.
Kawamata H et al.
Human Molecular Genetics, 2008
Informatics-assisted protein profiling in a transgenic mouse model of amyotrophic lateral sclerosis.
Lukas TJ et al.
Molecular & Cellular Proteomics : Mcp, 2006
Mitochondrial proteomic analysis of a cell line model of familial amyotrophic lateral sclerosis.
Fukada K et al.
Molecular & Cellular Proteomics : Mcp, 2004
Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes.
Andersen PM et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 2003
Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis.
Menzies FM et al.
Brain : a Journal of Neurology, 2002
Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord.
Olsen MK et al.
Annals of Neurology, 2001
Selective changes in mitochondria respiratory properties in oxidative or glycolytic muscle fibers isolated from G93AhumanSOD1 transgenic mice.
Leclerc N et al.
Neuromuscular Disorders : Nmd, 2001
Mutation screening of manganese superoxide dismutase in amyotrophic lateral sclerosis.
Tomkins J et al.
Neuroreport, 2001
Superoxide dismutase-1 mutation-related neurotoxicity in familial amyotrophic lateral sclerosis.
Shibata N et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 2000
Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.
Andreassen OA et al.
Annals of Neurology, 2000
Oxidative stress and motor neurone disease.
Cookson MR et al.
Brain Pathology (zurich, Switzerland), 1999
Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis.
Browne SE et al.
Journal of Neurochemistry, 1998
Genetics of amyotrophic lateral sclerosis.
Siddique T et al.
Human Molecular Genetics, 1996